Alison Coutts
Executive Chairman |
Memphasys Ltd.
30 Richmond Road,
2140 Homebush West (AUS)
alison.coutts@memphasys.com
+61 2 8415 7300
Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)
April 2nd, 2020
Memphasys Ltd (ASX: MEM) is an Australian publicly-listed bio-separations company developing and commercialising innovative separation techniques based on the Company's proprietary membrane technology. Memphasys’ first application of this technology platform is now being commercialised – the separation of the ‘best’ sperm from a semen sample for use in human in vitro fertilisation (IVF).
Thomas Soltau
CEO |
wallstreet:online capital AG
Michaelkirchstraße 17/18,
10179 Berlin (D)
service@smartbroker.de
+49 30 27 57 76 464
Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch
December 23rd, 2019
The wallstreet:online group is expanding. A new online broker will expand the business model of the largest online financial community in the German-speaking region. In an interview, Thomas Soltau, member of the Board of Management, explains the strategy for the new "smartbroker". The plans are clearly defined; in the coming years, 200,000 customers are to be acquired for the online transaction business. With FondsDISCOUNT.de, wallstreet:online capital AG has already successfully established a leading independent fund broker on the Internet.